Wilmington, MA, United States of America

Fangming Zou

This inventor holds 1 USPTO granted patent. Top assignee: Ucb S.a.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fangming Zou. Retrieved from https://idiyas.com/inventor/fangming-zou-uzyycgcm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Fangming Zou

Introduction: Fangming Zou is a notable inventor based in Wilmington, MA (US). He has made significant contributions to the field of analgesics through his innovative research and development. His work focuses on the combination of muscarinic agonists with various analgesic drugs, aiming to enhance pain relief methods.

Latest Patents: Fangming Zou holds a patent for an invention titled "Analgesic combination of muscarinic agonists." This invention relates to the combination of muscarinic agonists with narcotic analgesics, non-steroidal anti-inflammatory drugs, or other analgesic drugs. The primary goal of this invention is to provide effective antinociception, or pain relief, by utilizing a specific class of M4 selective muscarinic agonists in conjunction with traditional analgesic medications. He has 1 patent to his name.

Career Highlights: Throughout his career, Fangming Zou has demonstrated a commitment to advancing pain management solutions. His work has been instrumental in exploring new avenues for combining existing analgesic therapies with muscarinic agonists, which could lead to improved patient outcomes.

Collaborations: Fangming Zou collaborates with James Ellis, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and developing effective therapeutic solutions.

Conclusion: Fangming Zou's contributions to the field of analgesics highlight the potential for innovative combinations of existing drugs to enhance pain relief. His work continues to pave the way for future advancements in pain management therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…